Dysmenorrhea, Infertility, Female, Metrorrhagia, Pathology, Radiography, Ultrasonography
Conditions
Keywords
adenomyosis, diagnosis, treatment, epidemiology, Complications
Brief summary
To set up a Cooperative Network by enrolling 5000 patients with Adenomyosis(AM) from multiple centers.Based on the Network platform and Database,the investigators try to explore the diagnostic strategies for AM and carry out epidemiological survey on the semeiology of AM.In addiction,the investigators expect to conduct research on the effect and the follow-up fertility outcomes of different medical or surgical treatment, the etiology of AM and endometriosis,the perspective investigation of the malignant transformation of AM ;the high-risk factors of AM,and finally propel the formation of Expert Consensus and Clinical Guidelines about AM which suitable to chinese conditions.
Detailed description
5000 women diagnosed of Adenomyosis(AM) with pathology, transvaginal ultrasonography or magnetic resonance image(MRI)will be enrolled from nationwide multicenters. The investigators would build up Network platform, and database with the registered data within 6 months. 30-month follow-up with an interval of at least once every 6 months will be done for every patient ,and update the database timely. Based on the Network platform and Database,we try to explore the diagnostic strategies for AM and carry out epidemiological survey on the semeiology of AM.In addiction,the investigators expect to conduct research on the effect and the follow-up fertility outcomes of different medical or surgical treatment,the etiology of AM and endometriosis,the perspective investigation of the malignant transformation of AM ;the high-risk factors of AM,and finally propel the formation of Expert Consensus and Clinical Guidelines about AM which suitable to chinese conditions.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Women diagnosed of adenomyosis by pathology, transvaginal ultrasound or MRI.
Exclusion criteria
* Refusal to join the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Therapeutic effect and Diagnostics | 2day | Symptom Assessment |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| selection of therapeutic scheme | 1day | pharmacotherapy or surgery |
| vision algetic standard(VAS) | 2day | Semeiology and evaluative criteria |
| Pathology | 1day | Diagnostic assessment |
| Magnetic Resonance Imaging | 1day | Diagnostic assessment |
| pictorial blood loss assessment chart(PBAC) | 2day | Semeiology and evaluative criteria |
| B type ultrasound | 1day | Diagnostic assessment |
Countries
China